KIT and renal carcinoma: These cells contribute to the process of metastasis in various solid tumors, such as lung cancer [6], renal carcinoma [40], and thyroid tumors, by activating the KIT signaling pathway and its downstream pathways (MAPK and P13K), which promote cell proliferation and survival [41].